MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells
Authors:
- 1 June 2014
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 26 (6) , 1347-1354
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81228005, 81272690)
This publication has 36 references indexed in Scilit:
- Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3British Journal of Pharmacology, 2013
- The structure and function of the S1P1 receptorTrends in Pharmacological Sciences, 2013
- Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestationsWorld Journal of Hepatology, 2013
- Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated CancerCancer Cell, 2013
- The functional roles of S1P in immunityThe Journal of Biochemistry, 2012
- FXR ligands protect against hepatocellular inflammation via SOCS3 inductionCellular Signalling, 2012
- S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic SitesCancer Cell, 2012
- Sphingosine 1-phosphate signalling in cancerBiochemical Society Transactions, 2012
- Sphingosine-1-phosphate and immune regulation: trafficking and beyondTrends in Pharmacological Sciences, 2011
- STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumorsNature Medicine, 2010